Weekly epidemiological record 1 October 2021 No 39, 2021, 96, 477–484 Report from IACO30: Disruption of ivermectin mass drug administration in the Yanomami focus
Authors: Emily Toubali, Molly Brady, Ernest Mensah, Aryc Mosher, Emily Wainwright, Liz Eddy, Aria Gray, and Alyssa Jordan Multi-country experiences in implementing a direct
Authors: Elizabeth Fitch, Alison Krentel, Kevin Bardosh, Beth Sutherland, Alyssa Jordan, and Margaret Baker The World Health Organization’s 2021-2030 NTD Road Map advocates for
Part of the Act to End NTDS | East technical brief series June 2021. To eliminate human onchocerciasis transmission of the filarial parasite Onchocerca
Onchocerciasis: diagnostic target product profile to support preventive chemotherapy. WHO, 2021. Overview Onchocerciasis, also known as river blindness, affects an estimated 21 million people,
Overview The WHO Department of Control of Neglected Tropical Diseases (NTD) manages a diverse portfolio of twenty diseases, each with its own unique epidemiological
Weekly epidemiological record 2 October 2020 No 40, 2019, 484-487 Progress in eliminating onchocerciasis in the WHO Region of the Americas: advances towards transmission
This is footage[1] of microfilariae was captured in a 59-year-old man’s anterior chamber of the eye. The man lives in an onchocerciasis-endemic area in
This short film reveals the dedication of Edoa Pierre, a community drug distributor, as he works towards eliminating onchocerciasis (river blindness) in Nlongbon, Cameroon,
This research article focuses on the results of four rounds of mass drug administration (MDA) for cross-border districts of Côte d’Ivoire where lymphatic filariasis
In order to confirm that transmission recrudescence or importation does not occur for lymphatic filariasis (LF) after mass drug administration (MDA), the WHO recommends
This research article examines the Ov16 (onchocerciasis) and Wb123 (lymphatic filariasis) seroprevalence in the Bakoye and Falémé foci in Mali after 24 – 25
This editorial from Darin S. Evans raises important questions regarding the decision to stop mass drug administration (MDA) for countries with onchocerciasis as they
This research paper focuses on the first stop-Mass Drug Administration (MDA) decision for onchocerciasis in Nigeria. These findings can be modeled by other African
This research paper details the coordinated stop of MDA, decided by Sudan and Ethiopia, due to satisfying the World Health Organization’s criteria for interruption
